Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 56 | 2024 | 2060 | 7.510 |
Why?
|
| Thalamic Nuclei | 15 | 2024 | 18 | 5.280 |
Why?
|
| Image Enhancement | 28 | 2019 | 189 | 4.760 |
Why?
|
| Image Interpretation, Computer-Assisted | 23 | 2020 | 168 | 3.760 |
Why?
|
| Imaging, Three-Dimensional | 19 | 2019 | 275 | 3.590 |
Why?
|
| Image Processing, Computer-Assisted | 24 | 2024 | 654 | 3.570 |
Why?
|
| White Matter | 10 | 2024 | 114 | 3.270 |
Why?
|
| Brain Mapping | 7 | 2024 | 228 | 2.660 |
Why?
|
| Algorithms | 26 | 2020 | 976 | 1.980 |
Why?
|
| Thalamus | 8 | 2024 | 64 | 1.740 |
Why?
|
| Signal Processing, Computer-Assisted | 8 | 2017 | 96 | 1.690 |
Why?
|
| Multiple Sclerosis | 9 | 2024 | 207 | 1.510 |
Why?
|
| Echo-Planar Imaging | 7 | 2016 | 33 | 1.450 |
Why?
|
| Alcoholism | 7 | 2024 | 309 | 1.300 |
Why?
|
| Artifacts | 9 | 2018 | 127 | 1.220 |
Why?
|
| Brain | 8 | 2021 | 1488 | 1.110 |
Why?
|
| Sensitivity and Specificity | 22 | 2017 | 1093 | 1.020 |
Why?
|
| Ventral Thalamic Nuclei | 3 | 2020 | 7 | 0.960 |
Why?
|
| Magnetic Resonance Angiography | 10 | 2011 | 178 | 0.930 |
Why?
|
| Data Compression | 4 | 2018 | 9 | 0.820 |
Why?
|
| Essential Tremor | 5 | 2021 | 17 | 0.820 |
Why?
|
| Humans | 79 | 2024 | 59360 | 0.800 |
Why?
|
| Reproducibility of Results | 20 | 2017 | 1561 | 0.780 |
Why?
|
| Contrast Media | 12 | 2019 | 408 | 0.770 |
Why?
|
| Adult | 37 | 2024 | 15669 | 0.710 |
Why?
|
| Female | 51 | 2024 | 30705 | 0.700 |
Why?
|
| Kidney | 4 | 2019 | 416 | 0.700 |
Why?
|
| HIV Infections | 3 | 2024 | 913 | 0.690 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 101 | 0.680 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 90 | 0.660 |
Why?
|
| Male | 46 | 2024 | 27739 | 0.660 |
Why?
|
| Back Pain | 1 | 2019 | 48 | 0.650 |
Why?
|
| Adipose Tissue | 4 | 2014 | 283 | 0.600 |
Why?
|
| Spine | 1 | 2018 | 42 | 0.590 |
Why?
|
| Middle Aged | 33 | 2024 | 16317 | 0.590 |
Why?
|
| Breath Holding | 3 | 2015 | 7 | 0.560 |
Why?
|
| Physics | 1 | 2017 | 12 | 0.560 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 37 | 0.550 |
Why?
|
| Breast Neoplasms | 6 | 2016 | 1118 | 0.530 |
Why?
|
| Alzheimer Disease | 4 | 2021 | 679 | 0.520 |
Why?
|
| Abdomen | 3 | 2014 | 91 | 0.510 |
Why?
|
| Cerebellum | 3 | 2021 | 91 | 0.500 |
Why?
|
| Pattern Recognition, Automated | 3 | 2018 | 51 | 0.490 |
Why?
|
| Aged | 24 | 2024 | 13416 | 0.490 |
Why?
|
| Renal Artery | 2 | 2011 | 31 | 0.470 |
Why?
|
| Aging | 4 | 2024 | 710 | 0.470 |
Why?
|
| Breast | 1 | 2016 | 173 | 0.460 |
Why?
|
| Neural Pathways | 4 | 2024 | 95 | 0.460 |
Why?
|
| Pulvinar | 2 | 2024 | 2 | 0.450 |
Why?
|
| Myocardial Infarction | 3 | 2013 | 862 | 0.450 |
Why?
|
| Young Adult | 10 | 2024 | 4267 | 0.440 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 8 | 0.420 |
Why?
|
| Hippocampus | 4 | 2024 | 246 | 0.420 |
Why?
|
| Deep Brain Stimulation | 3 | 2023 | 64 | 0.400 |
Why?
|
| Gadolinium | 2 | 2012 | 103 | 0.400 |
Why?
|
| Abdominal Neoplasms | 1 | 2012 | 17 | 0.390 |
Why?
|
| Renal Artery Obstruction | 1 | 2011 | 18 | 0.380 |
Why?
|
| Atrophy | 6 | 2024 | 76 | 0.380 |
Why?
|
| Neuroimaging | 2 | 2024 | 143 | 0.350 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2018 | 168 | 0.350 |
Why?
|
| Coronary Angiography | 4 | 2005 | 176 | 0.340 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 69 | 0.330 |
Why?
|
| Subtraction Technique | 4 | 2013 | 23 | 0.330 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 277 | 0.330 |
Why?
|
| Liver Diseases | 2 | 2015 | 138 | 0.320 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2007 | 107 | 0.310 |
Why?
|
| Phantoms, Imaging | 5 | 2019 | 216 | 0.300 |
Why?
|
| Kidney Diseases | 1 | 2009 | 169 | 0.290 |
Why?
|
| Aged, 80 and over | 10 | 2022 | 5128 | 0.280 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2018 | 55 | 0.260 |
Why?
|
| Cognitive Dysfunction | 3 | 2021 | 309 | 0.250 |
Why?
|
| Heart Ventricles | 2 | 2005 | 253 | 0.230 |
Why?
|
| Gadolinium DTPA | 4 | 2013 | 84 | 0.230 |
Why?
|
| Body Water | 2 | 2014 | 16 | 0.220 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1051 | 0.210 |
Why?
|
| Attention | 1 | 2024 | 146 | 0.210 |
Why?
|
| Liver | 3 | 2016 | 797 | 0.210 |
Why?
|
| Epilepsy | 1 | 2023 | 105 | 0.190 |
Why?
|
| Memory, Episodic | 1 | 2021 | 18 | 0.190 |
Why?
|
| Respiratory Mechanics | 2 | 2011 | 57 | 0.190 |
Why?
|
| Reference Values | 3 | 2014 | 326 | 0.180 |
Why?
|
| Prodromal Symptoms | 1 | 2021 | 15 | 0.180 |
Why?
|
| Alcohol Abstinence | 1 | 2021 | 10 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2020 | 2 | 0.180 |
Why?
|
| Computer Simulation | 3 | 2015 | 458 | 0.180 |
Why?
|
| Coronary Vessels | 4 | 2003 | 109 | 0.180 |
Why?
|
| Respiration | 6 | 2018 | 88 | 0.180 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2020 | 5 | 0.180 |
Why?
|
| Heart | 1 | 2002 | 274 | 0.170 |
Why?
|
| Red Nucleus | 1 | 2020 | 1 | 0.170 |
Why?
|
| Automation | 1 | 2020 | 51 | 0.170 |
Why?
|
| Cerebellar Nuclei | 1 | 2020 | 4 | 0.170 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 29 | 0.170 |
Why?
|
| Lymphatic Abnormalities | 1 | 2020 | 3 | 0.170 |
Why?
|
| Reflex, Stretch | 1 | 2019 | 2 | 0.170 |
Why?
|
| Urography | 2 | 2017 | 11 | 0.170 |
Why?
|
| Lymphography | 1 | 2020 | 11 | 0.170 |
Why?
|
| Learning | 1 | 2021 | 169 | 0.170 |
Why?
|
| Motion | 2 | 2018 | 57 | 0.170 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 1 | 0.160 |
Why?
|
| Aging, Premature | 1 | 2019 | 2 | 0.160 |
Why?
|
| Functional Laterality | 1 | 2019 | 133 | 0.160 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 4 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2016 | 3067 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2019 | 65 | 0.150 |
Why?
|
| Child | 5 | 2020 | 4174 | 0.140 |
Why?
|
| Sex Factors | 1 | 2019 | 935 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2016 | 15 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2020 | 6071 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 29 | 0.130 |
Why?
|
| Poisson Distribution | 1 | 2016 | 52 | 0.130 |
Why?
|
| Organometallic Compounds | 2 | 2014 | 63 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 292 | 0.120 |
Why?
|
| Meglumine | 1 | 2014 | 18 | 0.120 |
Why?
|
| Pancreas | 1 | 2015 | 147 | 0.120 |
Why?
|
| Lateral Thalamic Nuclei | 1 | 2014 | 1 | 0.120 |
Why?
|
| Gray Matter | 1 | 2014 | 31 | 0.110 |
Why?
|
| Knee Joint | 2 | 2019 | 285 | 0.110 |
Why?
|
| Adolescent | 6 | 2015 | 5824 | 0.110 |
Why?
|
| Magnetics | 1 | 2014 | 53 | 0.110 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2013 | 11 | 0.110 |
Why?
|
| Entorhinal Cortex | 1 | 2013 | 7 | 0.110 |
Why?
|
| Anatomic Landmarks | 1 | 2013 | 9 | 0.110 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 14 | 0.110 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 9 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2013 | 136 | 0.110 |
Why?
|
| Mammography | 2 | 2012 | 269 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 248 | 0.100 |
Why?
|
| Neuropil | 1 | 2012 | 6 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 145 | 0.100 |
Why?
|
| Executive Function | 2 | 2024 | 61 | 0.100 |
Why?
|
| Arteries | 1 | 2013 | 76 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2012 | 48 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2013 | 215 | 0.100 |
Why?
|
| Electrodes, Implanted | 2 | 2023 | 37 | 0.100 |
Why?
|
| Sample Size | 1 | 2012 | 61 | 0.100 |
Why?
|
| Memory | 2 | 2024 | 111 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2011 | 73 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2011 | 137 | 0.090 |
Why?
|
| Coronary Disease | 2 | 2002 | 244 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2010 | 33 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 206 | 0.080 |
Why?
|
| Fourier Analysis | 3 | 2016 | 32 | 0.080 |
Why?
|
| Feasibility Studies | 3 | 2007 | 525 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 371 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 2373 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 3617 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 674 | 0.070 |
Why?
|
| Head | 1 | 2007 | 53 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 158 | 0.060 |
Why?
|
| Observer Variation | 2 | 2018 | 205 | 0.060 |
Why?
|
| Stroke | 1 | 2014 | 1127 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2015 | 1782 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2005 | 50 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2005 | 13 | 0.060 |
Why?
|
| Connectome | 1 | 2024 | 29 | 0.060 |
Why?
|
| Spin Labels | 2 | 2015 | 12 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2024 | 59 | 0.060 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2004 | 11 | 0.060 |
Why?
|
| Diaphragm | 1 | 2004 | 21 | 0.060 |
Why?
|
| Ventricular Function | 1 | 2002 | 22 | 0.050 |
Why?
|
| Myocardium | 1 | 2005 | 264 | 0.050 |
Why?
|
| Oxides | 1 | 2002 | 33 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2013 | 914 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2002 | 65 | 0.050 |
Why?
|
| Systole | 1 | 2002 | 109 | 0.050 |
Why?
|
| Diastole | 1 | 2002 | 89 | 0.050 |
Why?
|
| Seizures | 1 | 2023 | 113 | 0.050 |
Why?
|
| Iron | 1 | 2002 | 136 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 66 | 0.050 |
Why?
|
| Comorbidity | 1 | 2024 | 1078 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1189 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2020 | 43 | 0.040 |
Why?
|
| Osteolysis, Essential | 1 | 2020 | 1 | 0.040 |
Why?
|
| Thoracic Duct | 1 | 2020 | 3 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2020 | 56 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2020 | 38 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 31 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 9 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2019 | 62 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 716 | 0.040 |
Why?
|
| Equipment Design | 2 | 2012 | 329 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2000 | 246 | 0.040 |
Why?
|
| Cognition | 1 | 2021 | 455 | 0.030 |
Why?
|
| Pelvis | 1 | 2016 | 58 | 0.030 |
Why?
|
| Methane | 1 | 1996 | 4 | 0.030 |
Why?
|
| Models, Structural | 1 | 1996 | 25 | 0.030 |
Why?
|
| Hydrocarbons | 1 | 1996 | 8 | 0.030 |
Why?
|
| Software | 2 | 2013 | 367 | 0.030 |
Why?
|
| Lactates | 1 | 1996 | 29 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 2015 | 20 | 0.030 |
Why?
|
| Multiphasic Screening | 1 | 2015 | 1 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 71 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1996 | 71 | 0.030 |
Why?
|
| Angiography | 1 | 2015 | 146 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 163 | 0.030 |
Why?
|
| Lipids | 1 | 1996 | 300 | 0.030 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2013 | 4 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 74 | 0.020 |
Why?
|
| Mental Recall | 1 | 2012 | 88 | 0.020 |
Why?
|
| Water | 1 | 2013 | 300 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1486 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2005 | 23 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 155 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 34 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2005 | 131 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 153 | 0.010 |
Why?
|
| Ferrosoferric Oxide | 1 | 2002 | 17 | 0.010 |
Why?
|
| Dextrans | 1 | 2002 | 45 | 0.010 |
Why?
|
| Magnetite Nanoparticles | 1 | 2002 | 28 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 589 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 523 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1997 | 32 | 0.010 |
Why?
|